review earn miss consensu oper seem track
per manag guidanc
celltrion hc cthc earn weaker street
expect op miss top line beat
attend earn event host ceo
posit top-lin strength driven sale push europ
given tight channel inventori guid manag
accord manag us inflectra end-market asp milder
eros qoq vs sale declin ceo re-affirmed new
biosimilar launch us truxima first-
mover cthc clarifi plan enter eu directli
neg us inflectra sale read bn mix
see softer end-market trend late remsima
sc procur sustain like launch year-end
suppress gpm fix cost burden may sequenti
rise remsima sc launch near
despit softer result revis tp
up target price-to-earnings multipl reflect improv oper result
ep tweak view downsid
celltrion inc cti vs cthc view cthc benefit
new product launch us/eu introduc no
earn miss top line came stronger celltrion
hc cthc result came may market close
earn weaker street expect op miss
top line beat attend earn event host
ceo find
compani data bloomberg profession servic cs estim
posit top-lin strength driven
sale push europ given tight channel
inventori guid
manag apprehend celltrion group effort
transpar market late manag short-term
guidanc event met accord manag
us inflectra end-market asp milder eros qoq vs
sale declin check ceo re-affirmed
new biosimilar launch us either truxima herzuma
guarante least truxima first-mov howev cthc
yet confirm account methodolog us profit-shar
teva still consult third-parti advisori
cthc clarifi plan enter eu directli gone
obtain sale licens respect european nation
recruit necessari talent qp sale repres
neg us inflectra sale read
bn mix total see softer end-
number share mn
chg prev ep
estimate pot chg tp
market trend late channel inventori us slower
uptak continu risk lead huge impact
 sale cancel remsima sc procur sustain
like launch year-end suppress gpm manag
say remsima sc requir longer lead time mth
biosimilar due addit procedur downstream product
packag pre-fil syring auto-injector etc learnt
celltrion group use oversea cmo could internalis dp
drug product capac recent announc fix
cost burden may sequenti rise remsima sc launch
near cthc plan recruit sale forc month ahead
plan launch impli increas labour cost
maintain neutral despit softer result revis tp
up target price-to-earnings multipl accord
celltrion inc cti reflect improv oper result cthc
ep tweak continu view
downsid cti vs cthc view cthc benefit
new product launch us/eu
figur cthc prepar eu direct distribut
figur cthc trade premium
figur cthc reach higher end
statu non-u analyst us disclosur credit suiss seek busi compani cover research report result investor
awar firm may conflict interest could affect object report investor consid report singl factor make invest
charl martineau pm univers toronto compani mention price
ray certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
price rate histori celltrion healthcar co ltd
signifi initi assumpt coverag
price rate histori celltrion inc
signifi initi assumpt coverag
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst
coverag univers consist compani cover analyst within relev sector outperform repres
attract neutral less attract underperform least attract invest opportun octob
canadian well european rate base stock total return rel analyst coverag univers consist
compani cover analyst within relev sector outperform repres attract neutral less attract
underperform least attract invest opportun latin american asia stock exclud japan australia rate
base stock total return rel averag total return relev countri region benchmark india bse sensex index
prior octob canadian rate base stock absolut total return potenti current share price
rel attract stock total return potenti within analyst coverag univers australian new zealand stock
expect total return calcul includ roll dividend yield outperform rate assign greater
equal under-perform less equal neutral may assign
overlap rate rang allow analyst assign rate put context associ risk prior may
rang outperform under-perform rate overlap neutral threshold oper
charl martineau pm univers toronto restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
circumst
rate nr credit suiss equiti research invest rate view stock secur relat
compani time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate
invest view equiti secur compani relat product
volatil indic stock defin volatil stock price move month least
past month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or
valuat sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover multipl sector
credit suiss distribut stock rate bank client
purpos nyse finra rate distribut disclosur requir stock rate outperform neutral under-perform
